Jonathan Yong
Stock Analyst at UBS
(2.60)
# 2,116
Out of 5,133 analysts
95
Total ratings
59.26%
Success rate
11.27%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Upgrades: Neutral | $12 → $17 | $17.38 | -2.19% | 10 | Jan 9, 2026 | |
| EHTH eHealth | Maintains: Neutral | $7 → $5 | $3.81 | +31.23% | 6 | Aug 7, 2025 | |
| CLOV Clover Health Investments | Maintains: Neutral | $4.5 → $3 | $2.54 | +18.11% | 4 | Aug 6, 2025 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $10.95 | +9.59% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $2.86 | +179.72% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $8.47 | +207.15% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $32.20 | -56.52% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $75.82 | +26.62% | 3 | Aug 8, 2023 | |
| SEM Select Medical Holdings | Maintains: Neutral | $29 → $32 | $14.91 | +114.62% | 3 | Aug 7, 2023 | |
| AMN AMN Healthcare Services | Maintains: Outperform | $115 → $105 | $15.32 | +585.38% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $100.30 | -20.24% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $253.98 | -9.05% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $6.99 | +286.27% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $208.26 | -51.98% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $823.98 | -45.39% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $2.47 | +385.83% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $4.72 | +1,383.05% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $19.29 | -11.87% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $180.93 | +93.44% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $12.55 | +656.97% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $2.31 | +267.97% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $23.05 | +77.87% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.29 | +158.36% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $79.86 | +6.44% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $179.96 | -18.87% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $45.76 | +131.64% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $201.81 | -22.20% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $271.81 | +35.39% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $273.96 | +131.79% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $80.68 | +45.02% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $22.17 | +35.32% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $479.32 | -37.83% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $199.19 | -52.31% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $333.93 | +48.23% | 1 | Oct 15, 2021 |
Oscar Health
Jan 9, 2026
Upgrades: Neutral
Price Target: $12 → $17
Current: $17.38
Upside: -2.19%
eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $3.81
Upside: +31.23%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5 → $3
Current: $2.54
Upside: +18.11%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $10.95
Upside: +9.59%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $2.86
Upside: +179.72%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $8.47
Upside: +207.15%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $32.20
Upside: -56.52%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $75.82
Upside: +26.62%
Select Medical Holdings
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $14.91
Upside: +114.62%
AMN Healthcare Services
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $15.32
Upside: +585.38%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $100.30
Upside: -20.24%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $253.98
Upside: -9.05%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $6.99
Upside: +286.27%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $208.26
Upside: -51.98%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $823.98
Upside: -45.39%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $2.47
Upside: +385.83%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $4.72
Upside: +1,383.05%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $19.29
Upside: -11.87%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $180.93
Upside: +93.44%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $12.55
Upside: +656.97%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $2.31
Upside: +267.97%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $23.05
Upside: +77.87%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.29
Upside: +158.36%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $79.86
Upside: +6.44%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $179.96
Upside: -18.87%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $45.76
Upside: +131.64%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $201.81
Upside: -22.20%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $271.81
Upside: +35.39%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $273.96
Upside: +131.79%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $80.68
Upside: +45.02%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $22.17
Upside: +35.32%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $479.32
Upside: -37.83%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $199.19
Upside: -52.31%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $333.93
Upside: +48.23%